Home › Rett Syndrome › NCT05432349
Rett Syndrome Registry
Rett Syndrome Real World Data Observational Registry
Who can join
Ages 0 to 99 · All sexes
Full eligibility criteria
Inclusion Criteria: * Male or female with a pathologic loss of function alteration of MECP2 Exclusion Criteria: * Male or female with a gain of function alteration of MECP2, including those with MEPC2 duplication or triplication
About the study
The Rett Syndrome Registry is a longitudinal observational study of individuals with MECP2 mutations and a diagnosis of Rett syndrome. Designed together with the IRSF Rett Syndrome Center of Excellence Network medical directors, this study collects data on the signs and symptoms of Rett syndrome as reported by the Rett syndrome experts and by the caregivers of individuals with Rett syndrome. This study will be used to develop consensus based guidelines for the care of your loved ones with Rett syndrome and to facilitate the development of better clinical trials and other aspects of the drug development path for Rett syndrome.
Sponsor: International Rett Syndrome Foundation · Participants: 3,000 · Started: Aug 2, 2022
Contact the study team
- Dominique Pichard · Phone: 513-874-3020
Official record on ClinicalTrials.gov — NCT05432349
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.